OTC · Biotechnology

Genus plc (GENSF) Stock

$31.07 +0.00% OTC: GENSF Healthcare

Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development.

Valuation

MetricValue
Price$31.07
Market Cap$2.06B
P/E Ratio30.03
P/B Ratio2.83
P/S Ratio2.14
EPS (TTM)$1.03
52-Week High$37.25
52-Week Low$26.01
Dividend Yield0.97%

Financials & Margins

MetricValue
ROE9.70%
ROA5.16%
ROCE8.35%
Gross Margin100.07%
Operating Margin9.78%
Net Margin7.07%
Debt/Equity0.52
Current Ratio2.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$574.0M$593.0M$690.0M$669.0M$673.0M
Operating Profit$62.0M$57.0M$41.0M$6.0M$42.0M
Net Profit$47.0M$41.0M$33.0M$8.0M$19.0M
EPS$0.72$0.62$0.50$0.12$0.25
Op Margin10.7%9.5%5.9%1.0%6.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$851.0M$1.0B$1.0B$1.0B$899.0M
Total Liabilities$354.0M$446.0M$440.0M$485.0M$423.0M
Cash$46.0M$39.0M$36.0M$43.0M$48.0M
Borrowings$152.0M$224.0M$232.0M$291.0M$266.0M

Latest News

How The Genus (LSE:GNS) Investment Narrative Is Shifting With Updated Fair Value Assumptions Simply Wall St. · May 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$68.0M$34.0M$50.0M$30.0M$67.0M
Investing Cash Flow$-75.0M$-109.0M$-66.0M$-44.0M$-32.0M
Financing Cash Flow$-2.0M$-12.0M$-1.0M$-14.0M$-20.0M
Net Cash Flow$5.0M$-7.0M$-2.0M$6.0M$6.0M
Free Cash Flow$39.0M$-8.0M$15.0M$5.0M$49.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA14.40
FCF Yield3.98%
Quick Ratio1.70
Interest Coverage3.49
Return 1Y20.54%
Return 3Y-8.49%
Return 5Y-55.34%

Ownership

Insiders Held0.60%
Institutions Held79.62%
Institutions Float Held80.10%
Institutional HolderSharesReport Date
T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Discovery Fd.1,203,1672026-04-30
SmallCap World Fund Inc1,124,7302026-03-31
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund955,6312026-04-30
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund633,8382026-03-31
Intl Growth & Income Fd.-Intl Growth and Income Fd.552,2542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BOEUFBonesupport Holding AB (publ) $20.49 +0.00% 64.38 $1.34B 0.00%
BRCTFBioArctic AB (publ) $31.78 -9.20% 125.73 $2.82B 2.61%
CSPHFCStone Pharmaceuticals $0.71 +0.00% -19.48 $1.14B 0.00%
GRRMFGerresheimer AG $33.35 +0.00% -3.12 $1.15B 0.15%
GTBIFGreen Thumb Industries Inc. $7.11 -0.70% 13.77 $1.65B 0.00%

About Genus plc

Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supplies breeding pigs and boar semen, enabling the production of swine with specific traits for pork processing. Furthermore, under the ABS, Genus, and Bovec labels, it provides bull semen and bovine embryos to facilitate the breeding of calves with targeted characteristics for dairy and beef output. Genus plc also extends specialized technical support to agricultural producers. Established in 1994, the company's headquarters are located in Basingstoke, United Kingdom.

Genus plc is headquartered in GB.

Genus plc (GENSF) stock trades at $31.07 with a market capitalization of $2.06B. The stock is valued at a price-to-earnings (P/E) ratio of 30.03, price-to-book of 2.83, price-to-sales of 2.14. Over the past 52 weeks the stock has ranged between $26.01 and $37.25, and currently trades 16.6% below its 52-week high. It pays a dividend yielding 0.97%.

On profitability, Genus plc generates a return on equity (ROE) of 9.70%, return on capital employed of 8.35%, an operating margin of 9.78%, a net profit margin of 7.07%.

Official website: www.genusplc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides